Continuous subcutaneous insulin infusion in young girls: a two-year follow-up study
DOI:
https://doi.org/10.1002/edn.74Keywords:
CSII, children, adolescents, females, type 1 diabetesAbstract
AbstractAims: To investigate why young girls decided to start continuous subcutaneous insulin infusion (CSII) therapy, and to examine their opinions and concerns with regard to using an insulin pump. In addition, the girls were evaluated for HbA1c values, insulin requirements and body mass index standard deviation score (BMI SDS) over a period of two years after starting CSII compared with a group of girls using multiple daily injections (MDI).
Methods: Twelve girls (mean age 10.8 years) starting CSII were followed over a period of two years. Why the girls started CSII and whether they preferred CSII or MDI were investigated. Their statements about CSII were analysed and categorised by two paediatric diabetes nurses. On four occasions HbA1c values, insulin requirement and BMI SDS were collected and compared with those of a control group of 12 girls using MDI for the same period of time.
Results: The girls started CSII due to a desire to test pump therapy, and their experiences of unstable blood glucose. They preferred CSII to MDI. The main positive statements were categorised as ‘quality-of-life benefits’. The main negative category was ‘the pump gets in the way’. In the CSII group, HbA1c decreased from 8.5 (7.4–9.5) to 7.5 (6.9–8.1) (p<0.05) over two years, and the insulin requirement decreased by 30%. In the control group these values were unchanged. There were no changes in the BMI SDS mean values for either group.
Conclusion: CSII was well accepted by the young girls, facilitated a decrease in HbA1c values, and did not result in weight gain.
Downloads
References
The Diabetes Control and Complication Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
Williams RM, Dunger DB. Insulin treatment in children and adoles-cents. Acta Paediatr 2004; 93: 440–446.
SWEDIABKIDS report 2005. The Swedish childhood diabetes registry 0-18 years. Diabetolognytt 2006; 8: 1–27.
Tamborlane WV, Shervin RS, Genel M, et aL. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979; 300: 573–578.
Ahern JA, Boland E, Doane R, et aL. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA„ levels across all age groups. Pediatr Diabetes 2002; 3: 10–15.
Maniatis A, Toig S, Klingensmith G, et aL. Life with continuous subcutaneous insulin infusion (CSII) therapy: child and parental perspectives and predictors of metabolic control. Pediatr Diabetes 2001; 2: 51–57.
McMahon SK, Airey FL, Marangou DA, et aL. Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med 2004; 22: 92–96.
Sulli N, Shashaj B. Long-term benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes: a 4-year follow-up. Diabet Med 2006; 23: 900–906.
Hands R. Selection for and initiation of continuous subcutaneous insulin infusion. Horm Res 2002; 57: 101–104.
Low K, Massa L, Lehman D, et aL Insulin pump in young adolescents with type 1 diabetes: a descriptive study. Pediatr Diabetes 2005; 6: 22–31.
Boland E, Ahern J, Grey M. A primer on the use of insulin pumps in adolescents. Diabetes Educ 1998; 24: 78–87.
Boland E, Fredrickson L, Grey M, et aL. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycaemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999; 22: 1779–1784.
Maniatis A, Klingensmith G, Slover R, et aL. Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. Pediatrics 2001; 107: 351–356.
Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injec-tions in patient with type 1 diabetes: meta-analysis of randomised controlled trials. BMJ2002; 324: 1–6.
Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin therapy, a meta-analysis. Diabetes Care 2003; 26: 1079–1087.
Schiaffini R, Ciampalini P, Spera S, et aL. An observational study com-paring continuous subcutaneous insulin infusion (CSII) and insulin glargine in children with type 1 dia-betes. Diabetes Metab Res Rev 2005; 21: 347–352.
Weintrobe N, Benzaquen H, Galatzer A, et al. Comparison of continuous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomised open crossover trial. Pediatrics 2003; 112: 559–564.
Gift A. Visual analogue scales: meas-urement of subjective phenomena. Nurs Res 1989; 38: 286–288.
Rolland-Cachera MF, Sempe M, Guillioud-Bataille M, et al. Adiposity indices in children. Am J Clin Nutr 1982; 36: 178–184.
The Hvidövre Study Group. Good metabolic control is associated with better quality of life in 2101 adoles-cents with type 1 diabetes. Diabetes Care 2001; 24: 1923–1928.
Kaufman F, Halvorson, M, Miller D, et al. Insulin pump therapy in type 1 pediatric patients: now and into the year 2000. Diabetes Metab Res Rev 1999; 15: 338–352.
Wredling R, Hannerz L, Johansson U-B. Variability of blood glucose levels in patients treated with continuous subcutaneous insulin infusion: a pilot study. Practical Diabetes Int 1997; 14: 5–8.
National guidelines for diabetes mellitus type 1. (http:www.sos.se/FULLTEXT/9900-061/9900-061; last accessed 16 December 2006).
Kaufman F, Halvorson M, Devoe D, et aL. Insulin pump therapy in young children with diabetes. Diabetes Spectr 2001; 2: 84–88.
Burdick J, Chase P, Slover R, et aL. Missed insulin meal boluses and elevated haemoglobin A„ in children receiving insulin pump therapy. Pediatrics 2004; 113: 221–224.
Brown SA. Meta-analysis of diabetes education research: variations in intervention effect across studies. Res Nurs Health 1992; 15: 409–419.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2007 Copyright © 2007 FEND
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
